Business · 22/07/2022Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Three New Drug Applications from Multiple Holders
Summary
The Food and Drug Administration (FDA) has withdrawn the approval of three new drug applications due to repeated failure to submit required annual reports by the holders of those applications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →